4//SEC Filing
KAKKIS EMIL D 4
Accession 0000950170-24-135521
CIK 0001515673other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 6:44 PM ET
Size
7.1 KB
Accession
0000950170-24-135521
Insider Transaction Report
Form 4
KAKKIS EMIL D
DirectorPresident & CEO10% Owner
Transactions
- Gift
Common Stock
2024-12-09−20,000→ 2,203,985 total(indirect: By Trust) - Sale
Common Stock
2024-12-10$50.00/sh−8,273$413,650→ 2,195,712 total(indirect: By Trust)
Holdings
- 564,605
Common Stock
Footnotes (2)
- [F1]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
- [F2]Includes 8 shares acquired under the Company's A&R 2014 Employee Stock Purchase Plan on October 31, 2024.
Documents
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeother
Related Parties
1- filerCIK 0001248093
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 6:44 PM ET
- Size
- 7.1 KB